课题基金 / 基金详情

Degradation of the CDK inhibitor p27^<Kip1> by a novel ubiquitin ligase.

Degradation of the CDK inhibitor p27^<Kip1> by a novel ubiquitin ligase.
新型泛素连接酶降解 CDK 抑制剂 p27^<Kip1>。
批准号:
17590243
负责人:
UCHIDA Chiharu
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

UCHIDA Chiharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cell cycle progression is controlled by cyclin-dependent kinases (CDKs). The CDK activities are negatively regulated by CDK inhibitor proteins (CKIs). In the quiescent and early G1 phase, p27^<Kip1>, one of the Cip/Kip-type CKIs, exists in abundance in the cell nucleus to suppress cell cycle progression. p27^<Kip1> is degraded in late G1 phase by the ubiquitin-proteasome pathway, allowing cells to enter S phase. In this study, we identified p27NBP1 as a p27^<Kip1>-interacting protein. p27NBP1 physically interacted with p27^<Kip1> and directly ubiquitinated p27^<Kip1> in an intact RING finger domain-dependent manner. Since we isolated p27NBP1 as a protein that interacts with the amino-terminal portion of p27^<Kip1> containing Ser10, we next examined whether interaction between these two proteins was affected by Ser10 phosphorylation status. In spite of the substitution of Ser10, p27^<Kip1> mutants associated with p27NBP1 to an extent similar to that of wild-type p27^<Kip1>. This result suggested that p27NBP1 interacts with p27^<Kip1> regardless of the status of Ser10 phosphorylation. Ablation of endogenous p27NBP1 by small interfering RNA increased the steady-state level of p27^<Kip1> and decelerated p27^<Kip1> turnover. p27^<Kip1> was decreased in synchronization with accumulation of p27NBP1 in late G1 phase. Furthermore, depletion of p27NBP1 resulted in inhibition of cell cycle progression from G1 to S phase in a p53-independent manner. Overall, the results indicate that p27NBP1 acts as a negative regulator of p27^<Kip1> function by promoting ubiquitin-dependent proteasomal degradation.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.
与铜蓝蛋白血症相关的铜蓝蛋白基因突变的生化特征。
DOI: --
发表时间: 2006
期刊: Neuromolecular Med. 8
影响因子: --
作者: [Kono, S., et al.]
通讯作者: et al.
Ubiquitin-dependent degradation of adenovirus EIA protein is inhibited by BS69.
BS69 抑制腺病毒 EIA 蛋白的泛素依赖性降解。
DOI: --
发表时间: 2006
期刊: Biochem Biophys Res Commun. 339
影响因子: --
作者: [Isobe, T., et al.]
通讯作者: et al.
Degradation of Tob1 Mediated by SCF^<Kip2>-Dependent Ubiquitination.
由 SCF^<Kip2> 依赖性泛素化介导的 Tob1 降解。
DOI: --
发表时间: 2006
期刊: Cancer Res. 66
影响因子: --
作者: [Hiramatsu, Y., et al.]
通讯作者: et al.
DOI: 10.1158/0008-5472.can-06-2629
发表时间: 2006-12-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者: [Gao, Yun, Kitagawa, Kyoko, Kitagawa, Masatoshi]
通讯作者: Kitagawa, Masatoshi
16
    Multicultural Teacher Education Programs for Japanese Early Childhood Education with diverse learners
    • 批准号:
      24531030
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      UCHIDA Chiharu
    • 依托单位:
    Regulation of DNA replication and repair by ubiquitin or ubiquitin-like modification in cancer cells
    • 批准号:
      19590272
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      UCHIDA Chiharu
    • 依托单位:
    国内基金
    海外基金
    Ubiquitin B在逆转卵巢癌化疗耐药中的作用及机制研究
    • 批准号:
      81372806
    • 项目类别:
      面上项目
    • 资助金额:
      70.0万元
    • 批准年份:
      2013
    • 负责人:
      吴鹏
    • 依托单位:
    split-ubiquitin酵母双杂交筛选spatacsin互作蛋白及遗传性痉挛性截瘫关系的研究
    • 批准号:
      81000484
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      赵国华
    • 依托单位:
    Ubiquitin-proteasome系统在多发性肌炎/皮肌炎发病机制中的作用
    • 批准号:
      30170885
    • 项目类别:
      面上项目
    • 资助金额:
      16.0万元
    • 批准年份:
      2001
    • 负责人:
      王国春
    • 依托单位:
    斜纹夜蛾核多角体病毒融合基因ubiquitin-gp37的功能研究
    • 批准号:
      30170040
    • 项目类别:
      面上项目
    • 资助金额:
      6.0万元
    • 批准年份:
      2001
    • 负责人:
      庞义
    • 依托单位: